In a significant move that underscores the deepening business ties between the United States and Colombia, Sarah M. Aiosa has been named the new Chair of the U.S.-Colombia Business Council (USCBC) for the 2024-2025 period. Aiosa, the Senior Vice President and President of Latin America at MSD, known as Merck & Co. Inc. in the U.S. and Canada, is set to bring her extensive experience and innovative vision to the forefront of U.S.-Colombian relations.
A New Era of Leadership for USCBC under Sarah Aiosa
The USCBC, established in 2017, has been pivotal in fostering robust bilateral relationships between the two nations, advocating for the interests of top U.S. investors in Colombia. With U.S. foreign direct investment in Colombia surpassing $8 billion and U.S.-owned firms contributing significantly to the Colombian job market, the council plays a crucial role in the economic landscape of both countries.
Aiosa’s appointment comes at a time when the importance of public-private partnerships, especially in healthcare, is more pronounced than ever. Her leadership is expected to drive forward initiatives that not only enhance commercial ties but also address the region’s pressing healthcare needs.
A Vision for Health and Prosperity
With a 75-year legacy in Colombia, MSD has been instrumental in contributing to the well-being and sustainable development of communities. Under Aiosa’s leadership, the USCBC aims to bolster two-way trade ties and public-private collaboration, focusing on developing a resilient healthcare system through policies that promote innovation, competitiveness, investment, and technology adoption.
Aiosa’s commitment to fostering economic partnerships and mutual prosperity is poised to strengthen the bonds between the U.S. and Colombia, with a special emphasis on expanding the U.S. private sector’s footprint in Colombia.
Sarah Aiosa: A Trailblazer in Healthcare
Aiosa’s tenure at MSD has been marked by strategic direction and oversight of operations across Latin America, with nearly 5,000 employees under her wing. Her role in driving the USCBC’s Health Working Group has been pivotal, particularly in advancing public-private partnerships to build sustainable and resilient health systems.
Her recognition on Diversity Woman Magazine’s Power 100 List and as one of the 50 Most Powerful Latinas by ALPFA speaks volumes about her influence and the impact she is expected to make in her new role.
Embracing Digitalization and Innovation
In an exclusive conversation with Executive Forecast, Aiosa highlighted the evolution of MSD’s portfolio to align with scientific advancements, with a significant focus on oncology and immunology. She underscored the importance of embracing digitalization and technology to enhance operations and meet the diverse needs of the population across Latin America.
MSD’s commitment to research and development is evident in its substantial investment and participation in clinical trials within the region, contributing to global efforts in healthcare innovation.
A Call to Action
Aiosa’s vision for sustainable healthcare in Latin America is built on three pillars: robust data, innovative health financing, and streamlined regulatory processes. Her message to women aspiring to pursue similar roles is one of empowerment and adaptability, encouraging them to dream big and embrace change.
USCBC notes that with Aiosa’s appointment looks forward to a period of growth and innovation, with the ultimate goal of improving lives in Colombia and strengthening the U.S.-Colombia partnership.